Patent Assignment
Reel/Frame 059294/0317
Assignment of Assignor's Interest
Recorded: 2022-03-17
Pages: 4
Assignor
BAYER AKTIENGESELLSCHAFT
Executed: 2022-03-02
Assignee
BAYER HEALTHCARE LLC
100 BAYER BOULEVARD, WHIPPANY, NEW JERSEY, 07981-0915
Covered Properties
(4)
Combination of Regorafenib and Pd-1/Pd-L1(2) Inhibitors for Treating Cancer
Combination of Regorafenib and Pd-1/Pd-L1(2) Inhibitors for Treating Cancer
Application:
16/731,409 →
Publication:
US 2020/0155674
Combination of Regorafenib and Pd-1/Pd-L1(2) Inhibitors for Treating Cancer
Combination of Regorafenib and Pd-1/Pd-L1(2) Inhibitors for Treating Cancer
Application:
17/576,522 →
Publication:
US 2022/0133888
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 10, 2020
From: HOFF, SABINE; ROSE, LARS; ZOPF, DIETER; KIESSLING, FABIAN
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 051865/0770 →
Assignment of Assignor's Interest
Feb 11, 2020
From: HOFF, SABINE; ROSE, LARS; ZOPF, DIETER; KIESSLING, FABIAN
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 051781/0277 →
Assignment of Assignor's Interest
Feb 11, 2020
From: HOFF, SABINE; ROSE, LARS; ZOPF, DIETER; KIESSLING, FABIAN
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 051781/0397 →